Loading clinical trials...
Loading clinical trials...
A Phase II Study of Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal Metastasis
Conditions
Interventions
Bevacizumab, etoposide, cisplatin
Intrathecal methotrexate
Locations
1
Taiwan
Department of Oncology, National Taiwan University Hospital
Taipei, Taipei City, Taiwan
Start Date
January 1, 2011
Primary Completion Date
July 1, 2013
Completion Date
October 1, 2013
Last Updated
October 16, 2013
NCT05692635
NCT07191730
NCT06312176
NCT06797635
NCT07464470
NCT07003841
Lead Sponsor
National Taiwan University Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions